下载掌阅APP，畅读海量书库
立即打开
1.熊长明，郑亚国，何建国，等．2014版欧洲心脏病学会急性肺血栓栓塞症诊断治疗指南解读．中国循环杂志，2014，29 （11）：864-866．
2.中华医学会心血管病学分会，中国老年学学会心脑血管病专业委员会．华法林抗凝治疗的中国专家共识．中华内科杂志，2013，52 （1）：76-81．
3.葛卫红．华法林抗凝治疗临床药师指导手册．北京：人民卫生出版社，2009，11．
4. Linkins LA, Dans AL, Moores LK, et al. American College of Chest Physicians. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012, 141 (2 Suppl):e495S-530S.
5.钱晓华，夏晓华，张伟民．影响凝血试验室间质量评价结果的主要因素分析．临床检验杂志，2007，25 （4）：298-300．
6. Lee SC, Ng SS, Oldenburg J, et al. Interethnic variability of warfarin maintenance requirement is explained by VKORC1 genotype in an Asian population. Clin Pharmacol Ther, 2006, 79 : 197-205.
7. Konstantinides SV, Torbicki A, Agnelli G, et al. 2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J, 2014, 35 (43): 3033-3069.
8. van der Hulle T, Kooiman J, den Exter PL, et al. Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis. J Thromb Haemost, 2014, 12 (3): 320-328.
9. Schulman S, Kakkar AK, Goldhaber SZ, et al. Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis. Circulation, 2014, 129 (7): 764-772.
10. Büller HR, Prins MH, Lensin AW, et al. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. N Engl J Med, 2012, 366 (14): 1287-1297.
11. Agnelli G, Büller HR, Cohen A, et al. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med, 2013, 369 (9): 799-808.
12. Büller HR, Decousus H, Grosso MA, et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med, 2013, 369 (15): 1406-1415.
13. Kearon C, Akl EA, Ornelas J, et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest, 2016, 149 (2): 315-352.